ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
저엔도톡신 젤라틴 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 6.7%로 23억 8,000만 달러로 성장합니다. 예측 기간의 성장은 바이오의약품 연구개발 투자 증가, 재생의료 및 조직공학의 채택 증가, 세포배양 및 3D 바이오프린팅 용도 수요 증가, 비경구용 제품의 품질 기준 강화, 동물성 성분을 함유하지 않은 젤라틴으로의 전환 등에 기인하는 것으로 분석됩니다. 이 기간 중 예상되는 주요 동향으로는 재조합 젤라틴 및 식물 유래 저내독소 젤라틴 개발, 첨단 약물전달 시스템으로의 통합, 맞춤형 의료 제제 채택, 연구개발 증가, 내독소 시험 및 품질관리 프로세스 자동화 등이 있습니다.
재생의료에 대한 수요 증가는 향후 수년간 저독성 젤라틴 시장의 성장을 촉진할 것으로 예측됩니다. 재생의료는 인간의 세포, 조직, 장기를 복구, 대체, 재생, 정상 기능을 회복시키는 것을 목적으로 하는 치료법을 포함합니다. 이러한 수요 증가는 만성질환 증가로 인해 조직 재생을 지원하고 장기적인 결과를 개선하는 첨단 치료법에 대한 요구가 증가하고 있기 때문입니다. 저독성 젤라틴은 면역반응을 최소화하면서 세포 증식과 조직 형성을 촉진하는 안전하고 생체적합성이 높은 발판 역할을 함으로써 재생의료에서 중요한 역할을 담당하고 있습니다. 순도가 높기 때문에 섬세한 세포 치료 및 조직 공학에 특히 적합합니다. 예를 들어 2023년 7월 미국 유전자 및 세포치료학회(ASGCT)와 씨트라인(Citeline)은 2023년 1분기 말 기준, 임상 2상 시험 중인 유전자 치료제가 247개에 달한다고 보고했습니다. 이 수치는 5% 증가하여 2분기 말에는 260개에 달했습니다. 그 결과, 재생치료에 대한 수요가 증가하면서 저독성 젤라틴 시장의 성장에 기여하고 있습니다.
저내독소 젤라틴 시장의 주요 기업은 의약품 제제의 안전성과 성능을 향상시키기 위해 내독소 제어 부형제와 같은 첨단 제품 개발에 주력하고 있습니다. 내독소 제어 부형제는 내독소 수준을 최소화하기 위해 특별히 처리된 고도로 정제된 물질로, 의약품, 특히 주사제, 생물제제, 세포 기반 치료제와 같은 민감한 용도의 의약품에서 더 높은 안전성을 보장합니다. 예를 들어 젤라틴과 콜라겐 펩티드를 생산하는 독일 젤리타(GELITA)는 2025년 1월 VACCIPRO와 MEDELLAPRO를 발표했습니다. 고순도 의료용 젤라틴과 콜라겐 펩티드는 백신 안정화, 3D 바이오프린팅, 의료기기 등 특수한 생명과학 용도를 위해 제조된 고순도 의료용 젤라틴과 콜라겐 펩티드입니다. 이는 엄격한 내독소 관리 기준을 준수하여 제품의 안전성을 높이고 임상 및 제약 환경에서 환자의 건강을 보호합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 저엔도톡신 젤라틴 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 저엔도톡신 젤라틴 시장 : 성장률 분석
세계의 저엔도톡신 젤라틴 시장 실적 : 규모와 성장, 2019-2024
세계의 저엔도톡신 젤라틴 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 저엔도톡신 젤라틴 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 저엔도톡신 젤라틴 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
유형 A(산성 프로세스 젤라틴)
유형 B(알칼리법젤라틴)
세계의 저엔도톡신 젤라틴 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
돼지 젤라틴
소 젤라틴
생선 젤라틴
기타 제품 유형
세계의 저엔도톡신 젤라틴 시장 : 처방별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
분말
과립
액체
시트
기타 처방
세계의 저엔도톡신 젤라틴 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
약물전달 시스템
조직공학
세포배양
안정제
증점제
세계의 저엔도톡신 젤라틴 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
의약품
바이오테크놀러지
식품 및 음료
화장품
조사실
세계의 저엔도톡신 젤라틴 시장 : 서브 세분화, 유형 A(산성법젤라틴), 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
돈피 젤라틴
속경화 젤라틴
저개화 젤라틴
의약품 등급 A 유형
바이오테크놀러지 애플리케이션 등급
세계의 저엔도톡신 젤라틴 시장 : 서브 세분화, 유형 B(알칼리법젤라틴), 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
소가죽 젤라틴
고개화 젤라틴
천천히 녹는 젤라틴
주사 등급 유형 B
재생의료 등급
제7장 지역별·국가별 분석
세계의 저엔도톡신 젤라틴 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 저엔도톡신 젤라틴 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
저엔도톡신 젤라틴 시장 : 경쟁 구도
저엔도톡신 젤라틴 시장 : 기업 개요
Nagase & Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
Darling Ingredients Overview, Products and Services, Strategy and Financial Analysis
GELITA AG Overview, Products and Services, Strategy and Financial Analysis
PB Leiner Overview, Products and Services, Strategy and Financial Analysis
Nippi Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Nitta Gelatin Inc.
Weishardt Group
Sterling Biotech Limited
Narmada Gelatines Ltd.
Great Lakes Gelatin Company
Kenney & Ross Limited
Junca Gelatines SL
Trobas Gelatine BV
Lapi Gelatine S.p.a.
Ewald-Gelatine GmbH
Niksan Pharmaceutical
Geltech
India Gelatine & Chemicals Ltd.
Reinert Gruppe Ingredients GmbH
Jilin Tianzheng Biotechnology Co. Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
저엔도톡신 젤라틴 시장 2029 : 새로운 기회를 제공하는 국가
저엔도톡신 젤라틴 시장 2029 : 새로운 기회를 제공하는 부문
저엔도톡신 젤라틴 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Low endotoxin gelatin is a highly refined form of gelatin characterized by minimal endotoxin content, which helps minimize the risk of adverse immune reactions. It is specially formulated for use in sensitive biological applications such as drug delivery, tissue engineering, and regenerative medicine, where its high purity ensures compatibility with delicate cellular systems and biomedical settings.
The primary types of low endotoxin gelatin include type A (acid-processed) and type B (alkaline-processed) gelatin. Type A gelatin, derived from porcine skin through acid treatment, is known for its rapid solubility and high purity, making it suitable for quick-setting pharmaceutical and medical applications. Product variants include porcine gelatin, bovine gelatin, fish gelatin, and others, and they come in various forms such as powder, granules, liquid, sheets, and more. Low endotoxin gelatin is used in a wide range of applications, including drug delivery systems, tissue engineering, cell culture, as stabilizing agents, and as thickening agents. It serves multiple end-users, including pharmaceutical companies, biotechnology firms, food and beverage manufacturers, cosmetics producers, and research laboratories.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The low endotoxin gelatin market research report is one of a series of new reports from The Business Research Company that provides low endotoxin gelatin market statistics, including the low endotoxin gelatin industry global market size, regional shares, competitors with the low endotoxin gelatin market share, detailed low endotoxin gelatin market segments, market trends, opportunities, and any further data you may need to thrive in the low endotoxin gelatin industry. This low endotoxin gelatin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The low endotoxin gelatin market size has grown strongly in recent years. It will grow from $1.72 billion in 2024 to $1.84 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth during the historic period can be attributed to the increasing demand for biocompatible materials in pharmaceuticals, expanded use in vaccine and biologics production, heightened concerns about endotoxin contamination, advancements in gelatin purification techniques, and a growing regulatory emphasis on injectable-grade excipients.
The low endotoxin gelatin market size is expected to see strong growth in the next few years. It will grow to $2.38 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increased investment in biopharmaceutical research and development, rising adoption of regenerative medicine and tissue engineering, growing demand for cell culture and 3D bioprinting applications, stricter quality standards for parenteral products, and a shift toward animal-origin-free gelatin. Key trends expected during this period include the development of recombinant and plant-based low-endotoxin gelatin, integration into advanced drug delivery systems, adoption of personalized medicine formulations, increased research and development efforts, and the automation of endotoxin testing and quality control processes.
The increasing demand for regenerative medicine is expected to drive the growth of the low endotoxin gelatin market in the coming years. Regenerative medicine includes therapies that aim to repair, replace, or regenerate human cells, tissues, or organs to restore normal function. This growing demand is largely fueled by the rise in chronic diseases, which has led to a greater need for advanced treatments that support tissue regeneration and improved long-term outcomes. Low-endotoxin gelatin plays a critical role in regenerative medicine by serving as a safe and biocompatible scaffold that encourages cell growth and tissue formation while minimizing immune responses. Its high level of purity makes it particularly suitable for delicate cell therapies and tissue engineering. For example, in July 2023, the American Society of Gene & Cell Therapy (ASGCT) and Citeline reported that there were 247 gene therapies in Phase II clinical trials at the end of Q1 2023. This number rose by 5%, reaching 260 by the end of Q2. Consequently, the rising need for regenerative therapies is contributing to the growth of the low endotoxin gelatin market.
Leading companies in the low endotoxin gelatin market are emphasizing the development of advanced products like endotoxin-controlled excipients to improve the safety and performance of pharmaceutical formulations. Endotoxin-controlled excipients are highly refined substances specifically processed to minimize endotoxin levels, ensuring greater safety in pharmaceutical products, especially in sensitive applications such as injectables, biologics, and cell-based therapies. For instance, in January 2025, GELITA, a Germany-based producer of gelatin and collagen peptides, introduced VACCIPRO and MEDELLAPRO. These are high-purity, medical-grade gelatins and collagen peptides formulated for specialized bioscience uses, including vaccine stabilization, 3D bioprinting, and medical devices. They comply with strict endotoxin control standards to enhance product safety and safeguard patient health in clinical and pharmaceutical settings.
In March 2024, BIO INX, a Belgium-based developer of materials for 3D bioprinting, entered into a partnership with Rousselot to promote 3D bioprinting using high-quality gelatin-based biomaterials. This collaboration aims to advance both clinical and research use of 3D bioprinting by creating and distributing biomedical-grade bioinks made from Rousselot's X-Pure gelatin. Rousselot Inc. is a Netherlands-based manufacturer specializing in low-endotoxin gelatin.
Major players in the low endotoxin gelatin market are Nagase & Co. Ltd., Darling Ingredients, GELITA AG, PB Leiner, Nippi Inc., Nitta Gelatin Inc., Weishardt Group, Sterling Biotech Limited, Narmada Gelatines Ltd., Great Lakes Gelatin Company, Kenney & Ross Limited, Junca Gelatines SL, Trobas Gelatine BV, Lapi Gelatine S.p.a., Ewald-Gelatine GmbH, Niksan Pharmaceutical, Geltech, India Gelatine & Chemicals Ltd., Reinert Gruppe Ingredients GmbH, Jilin Tianzheng Biotechnology Co. Ltd., and Yasin gelatin.
North America was the largest region in the low endotoxin gelatin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in low endotoxin gelatin report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the low endotoxin gelatin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The low endotoxin gelatin market consists of sales of bovine bone-low-endotoxin gelatin, fish skin-low-endotoxin gelatin, and recombinant gelatin. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Low Endotoxin Gelatin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on low endotoxin gelatin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for low endotoxin gelatin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The low endotoxin gelatin market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Type A (Acid Process Gelatin); Type B (Alkaline Process Gelatin)
2) By Product Type: Porcine Gelatin; Bovine Gelatin; Fish Gelatin; Other Product Types
3) By Formulation: Powder; Granules; Liquid; Sheet; Other Formulations
4) By Application: Drug Delivery Systems; Tissue Engineering; Cell Culture; Stabilizing Agents; Thickening Agents
5) By End-User: Pharmaceuticals; Biotechnology; Food And Beverage; Cosmetics; Research Laboratories
Subsegments:
1) By Type A (Acid Process Gelatin): Porcine Skin Gelatin; Fast Setting Gelatin; Low Bloom Gelatin; Pharmaceutical Grade Type A; Biotech Application Grade
2) By Type B (Alkaline Process Gelatin): Bovine Hide Gelatin; High Bloom Gelatin; Slow Dissolving Gelatin; Injectable Grade Type B; Regenerative Medicine Grade
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Low Endotoxin Gelatin Market Characteristics
3. Low Endotoxin Gelatin Market Trends And Strategies
4. Low Endotoxin Gelatin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Low Endotoxin Gelatin Growth Analysis And Strategic Analysis Framework
5.1. Global Low Endotoxin Gelatin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Low Endotoxin Gelatin Market Growth Rate Analysis
5.4. Global Low Endotoxin Gelatin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Low Endotoxin Gelatin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Low Endotoxin Gelatin Total Addressable Market (TAM)
6. Low Endotoxin Gelatin Market Segmentation
6.1. Global Low Endotoxin Gelatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Type A (Acid Process Gelatin)
Type B (Alkaline Process Gelatin)
6.2. Global Low Endotoxin Gelatin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Porcine Gelatin
Bovine Gelatin
Fish Gelatin
Other Product Types
6.3. Global Low Endotoxin Gelatin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Powder
Granules
Liquid
Sheet
Other Formulations
6.4. Global Low Endotoxin Gelatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Delivery Systems
Tissue Engineering
Cell Culture
Stabilizing Agents
Thickening Agents
6.5. Global Low Endotoxin Gelatin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceuticals
Biotechnology
Food And Beverage
Cosmetics
Research Laboratories
6.6. Global Low Endotoxin Gelatin Market, Sub-Segmentation Of Type A (Acid Process Gelatin), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Porcine Skin Gelatin
Fast Setting Gelatin
Low Bloom Gelatin
Pharmaceutical Grade Type A
Biotech Application Grade
6.7. Global Low Endotoxin Gelatin Market, Sub-Segmentation Of Type B (Alkaline Process Gelatin), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bovine Hide Gelatin
High Bloom Gelatin
Slow Dissolving Gelatin
Injectable Grade Type B
Regenerative Medicine Grade
7. Low Endotoxin Gelatin Market Regional And Country Analysis
7.1. Global Low Endotoxin Gelatin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Low Endotoxin Gelatin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
